For help on how to get the results you want, see our search tips.
11 results
Medicine type
Biosimilar Remove Biosimilar filter
Generic Remove Generic filter
Orphan medicine Remove Orphan medicine filter
Additional monitoring Remove Additional monitoring filter
Application type
Initial authorisation Remove Initial authorisation filter
-
List item
Summary of opinion: Pemazyre
pemigatinib, opinion date: 28/01/2021, Positive, Last updated: 26/02/2021 -
List item
Summary of opinion: Thiotepa Riemser
thiotepa, opinion date: 28/01/2021, Positive, Last updated: 01/02/2021 -
List item
Summary of opinion: Alymsys
bevacizumab, opinion date: 28/01/2021, Positive, Last updated: 01/02/2021 -
List item
Summary of opinion: Abiraterone Accord
abiraterone, opinion date: 25/02/2021, Positive, Last updated: 26/02/2021 -
List item
Summary of opinion: Evrysdi
risdiplam, opinion date: 25/02/2021, Positive, Last updated: 26/02/2021 -
List item
Summary of opinion: Abevmy
bevacizumab, opinion date: 25/02/2021, Positive, Last updated: 26/02/2021 -
List item
Summary of opinion: Lextemy
bevacizumab, opinion date: 25/02/2021, Positive, Last updated: 26/02/2021 -
List item
Summary of opinion: Abiraterone Krka (new)
abiraterone acetate, opinion date: 22/04/2021, Positive, Last updated: 23/04/2021 -
List item
Summary of opinion: Celsunax (new)
ioflupane (123I), opinion date: 22/04/2021, Positive, Last updated: 23/04/2021 -
List item
Summary of opinion: Koselugo (new)
selumetinib, opinion date: 22/04/2021, Positive, Last updated: 23/04/2021 -
List item
Summary of opinion: Enspryng (new)
satralizumab, opinion date: 22/04/2021, Positive, Last updated: 23/04/2021